Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Janus II: A Feasibility Study to Evaluate Response to Remede Dual Channel System Therapy

NCT06556693 is registered in ClinicalTrials.gov with Zoll Medical Corporation as lead sponsor.

NCT NCT06556693
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06556693 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Janus II: A Feasibility Study to Evaluate Response to Remede Dual Channel System Therapy
Lead sponsor
Zoll Medical Corporation
Phase
Not applicable
Overall status
Recruiting
Start date
August 12, 2025
Completion date
December 31, 2034
Enrollment
40 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

sleep apnea